Почетна › Карцином на панкреасот › Калифорнија › Los Angeles
Клинички испитувања за Карцином на панкреасот во Los Angeles, CA
35 студии за Карцином на панкреасот бараат учесници на локации во и околу Los Angeles (во радиус од околу 30 милји). Отворете ја студијата за да видите кој може да учествува и како да го контактирате тимот.
Официјален текст на студијата (англиски)
Барате учесници за студија? Истакнете ја на врвот од оваа страница — $99 за 30 дена →
Study of AZD9574 as Monotherapy and in Combination With Anti-cancer Agents in Participants With Advanced Solid Malignancies
Се регрутираФаза 1/2
- Research Site, Los Angeles
A Study of LY4052031 in Participants With Advanced or Metastatic Urothelial Cancer or Other Solid Tumors
Се регрутираФаза 1
- UCLA Department of Medicine-Hematology/Oncology, Los Angeles
A Study to Learn About the Study Medicine Called PF-08046876 in People With Advanced Solid Tumors
Се регрутираФаза 1
- Ronald Reagan UCLA Medical Center, Los Angeles
- UCLA Department of Medicine-Hematology/Oncology, Los Angeles
A Study of PHN-012 in Patients With Advanced Solid Tumors
Се регрутираФаза 1
- PHN-012-001 Site, Los Angeles
A Study to Learn About the Medicine Ponsegromab in Adults With Cancer of the Pancreas Which Has Spread and Caused Significant Body Weight Loss and Fatigue
Се регрутираФаза 2/3
- Cedars-Sinai Cancer at Cedars-Sinai Medical Center, Los Angeles
- UCLA Department of Medicine - Hematology/Oncology, Los Angeles
Study of Daraxonrasib (RMC-6236) in Patients With Resected Pancreatic Ductal Adenocarcinoma (PDAC)
Се регрутираФаза 3
- Cedars-Sinai Cancer at Cedars-Sinai Medical Center, Los Angeles
- University of California, Los Angeles, Los Angeles
A Study to Evaluate Chemotherapy With or Without INCB161734 in Previously Untreated, KRAS G12D-Mutated Metastatic Pancreatic Ductal Adenocarcinoma
Се регрутираФаза 3
- Investigative Site US027, Los Angeles
- Investigative Site US036, Los Angeles
- Investigative Site US048, Los Angeles
A Study to Evaluate the Effectiveness and Safety of Setidegrasib, Given With Either mFOLFIRINOX or NALIRIFOX Chemotherapies, in People With Pancreatic Cancer
Се регрутираФаза 3
- Cedars-Sinai - Cedars-Sinai Medical Center, Los Angeles
Study of RAS(ON) Inhibitors in Patients With Gastrointestinal Solid Tumors
Се регрутираФаза 1/2
- Cedars-Sinai Cancer at Cedars-Sinai Medical Center, Los Angeles
- UCLA Hematology/Oncology- Santa Monica, Los Angeles
CREO - Microwave Ablation Feasibility Study
Се регрутира
- Cedars Sinai, Los Angeles
Biospecimen Collection to Identify Gene Mutations for High Risk Pancreatic Cancer in Pediatric Patients, INSPPIRE 2 Study
Се регрутираНабљудувачка студија
- Children's Hospital Los Angeles, Los Angeles
- Cedars Sinai Medical Center, Los Angeles
A Study to Evaluate Safety, Tolerability and Preliminary Activity of AGX101 in Participants With Advanced Solid Tumors
Се регрутираФаза 1
- USC/Norris Comprehensive Cancer Center, Los Angeles
Comparing the Clinical Impact of Pancreatic Cyst Surveillance Programs and Associated Biomarkers
Се регрутираНабљудувачка студија
- UCLA / Jonsson Comprehensive Cancer Center, Los Angeles
A Phase 2 Study of VS-7375 in Patients With KRAS G12D-Mutated Pancreatic Cancer
Се регрутираФаза 2
- START- Los Angeles, Los Angeles
- Cedars-Sinai Medical Center, Los Angeles
- Valkyrie Clinical Trials, Los Angeles
Alpha Radiation Emitters (DaRT) With Chemotherapy for the Treatment of Locally Advanced and Metastatic Pancreatic Cancer
Се регрутира
- Cedars-Sinai, Los Angeles
Safety, PK and Efficacy of QXL138AM in Patients With Solid Tumors and Multiple Myeloma
Се регрутираФаза 1
- University of Southern California, Los Angeles
- Cedars-Sanai Medical Center - Samuel Oschin Comprehensive Cancer, Los Angeles
- Cedars-Sanai Medical Center, Los Angeles
AB801 in Combination With Chemotherapy and Immunotherapy for the Treatment of Patients With Borderline Resectable, Locally Advanced or Metastatic Cholangiocarcinoma or Pancreatic Cancer
Се регрутираФаза 1
- UCLA / Jonsson Comprehensive Cancer Center, Los Angeles
A Study of MRG007 (ARR-217) in Patients With Advanced Solid Tumors
Се регрутираФаза 1
- ULCA, Los Angeles
A Study of MGC026 in Participants With Advanced Solid Tumors
Се регрутираФаза 1
- The Angeles Clinic and Research Institute, Los Angeles
ANO31905 in Combination With Chemotherapy for CLDN18.2-Positive Locally Advanced Unresectable or Metastatic Pancreatic Cancer
Се регрутираФаза 1/2
- California Research Institute, Los Angeles
Pancreatic Cancer Early Detection Consortium
Се регрутираНабљудувачка студијаДобредојдени се здрави волонтери
- Cedars-Sinai Medical Center, Los Angeles
- UCLA Health, Los Angeles
Safely Optimizing Body Weight With Mifomelatide (TCMCB07) in Patients With Newly Diagnosed Colorectal Cancer (CRC) or Pancreatic Ductal Adenocarcinoma (PDAC) Undergoing Chemotherapy
Се регрутираФаза 2
- Cedars-Sinai Medical Center, Los Angeles
EXoPERT EMERALD Clinical Study
Се регрутираНабљудувачка студијаДобредојдени се здрави волонтери
- City of Hope Duarte Cancer Center, Los Angeles
A Phase 1 Dose-escalation Trial of KST-6051 in Participants With Advanced Solid Tumors With Kirsten Rat Sarcoma Viral Oncogene Homolog (KRAS) Mutation
Се регрутираФаза 1
- Cedars-Sinai Medical Center, Los Angeles
Study to Assess Adverse Events and Pharmacokinetics in Adult Participants With Non-Small Cell Lung Cancer, Head and Neck Squamous Cell Carcinoma and Other Solid Tumors, Receiving Intravenous Infusion of Azirkitug Alone or in Combination(s) With Budigalimab, Bevacizumab, or Telisotuzumab Adizutecan
Се регрутираФаза 1
- USC Norris Comprehensive Cancer Center /ID# 279603, Los Angeles
A Trial of RSC-1255 for Treatment of Patients With Advanced Malignancies
Се регрутираФаза 1
- University of California, Los Angeles (UCLA) Department of Medicine - Hematology/Oncology, Los Angeles
A Study to Evaluate the Safety and Efficacy of Mesothelin-Targeting Logic-gated CAR T, in Participants With Solid Tumors That Express MSLN and Have Lost HLA-A*02 Expression
Се регрутираФаза 1/2
- UCLA Medical Center, Los Angeles
Comparative Effectiveness Trial of Two Supportive Cancer Care Delivery Models for Adults With Cancer
Се регрутира
- Oncology Institute for Hope and Innovation, Los Angeles
A Phase 1/2 Study of VS-7375 in Patients With KRAS G12D-Mutated Solid Tumors
Се регрутираФаза 1/2
- Cedars-Sinai Medical Center, Los Angeles
Virtual Reality for GI Cancer Pain to Improve Patient Reported Outcomes
Се регрутира
- Cedars-Sinai Medical Center, Los Angeles
A Phase II Nationwide, Fully Decentralized, Telemedicine Study of Pemigatinib in Adult Patients With Advanced or Metastatic Pancreatic Cancer With FGFR Genetic Alterations
Се регрутираФаза 2
- Ohio State University-Telemedicine, Los Angeles
A Study to Evaluate TROP2 ADC LCB84 Single Agent and in Combination With an Anti-PD-1 Ab in Advanced Solid Tumors
Се регрутираФаза 1/2
- Cedars Sinai Medical Center, Los Angeles
Study of Safety and Tolerability of BCA101 Monotherapy and in Combination Therapy in Patients With EGFR-driven Advanced Solid Tumors
Се регрутираФаза 1
- Keck School of Medicine of USC, Los Angeles
- UCLA, Los Angeles
APL-101 Study of Subjects With NSCLC With c-Met EXON 14 Skip Mutations and c-Met Dysregulation Advanced Solid Tumors
Се регрутираФаза 2
- Cedars-Sinai Medical Center - Samuel Oschin Comprehensive Cancer Institute, Los Angeles
A Trial of AMXI-5001 for Treatment in Patients With Advanced Malignancies
Се регрутираФаза 1/2
- University of California, Los Angles (UCLA) Department of Medicine - Hematology/Oncology, Los Angeles
Испитувања за Карцином на панкреасот во други градови
- Houston, TX61 студија
- New York City, NY60 студии
- Boston, MA43 студии
- Nashville, TN39 студии
- St. Louis, MO33 студии
- Arlington, VA33 студии
- Baltimore, MD31 студија
- San Antonio, TX31 студија
- Philadelphia, PA26 студии
- Tampa, FL26 студии
- Durham, NC24 студии
- San Diego, CA24 студии
Други студии во Los Angeles
- Рак на бели дробови со не-мали клетки87 студии
- Рак (сите типови)74 студии
- Рак на дојка73 студии
- Рак на простата61 студија
- Колоректален карцином59 студии
- Метастатски карцином57 студии
- Карцином на јајниците50 студии
- Рак на бели дробови45 студии
- Сквамозноклеточен карцином на глава и врат42 студии
- Рак на ендометриумот34 студии
- Меланом34 студии
- Трипл негативен рак на дојка27 студии
Од ClinicalTrials.gov, податоци преземени 6.10.2026. Секоја студија ги поставува своите услови за вклучување; тимот на студијата одлучува кој може да учествува.